FDA Clearance Tracker · P050053-S017
INFUSE BONE GRAFT
Last checked: Nov 20, 2026Latest source record: Jan 26, 2011 (this decision)Source: openFDAMethods & limitations
Decided
Jan 26, 2011
Approved
Time to decision
147 days
Received Sep 1, 2010. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P050053-S017
- Device name
- INFUSE BONE GRAFT
- Applicant
- Medtronic, Inc.
- Applicant location
- Memphis, TN
- Received
- Sep 1, 2010
- Decided
- Jan 26, 2011
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P050053
Device type
- Device class
- Class III
- Regulation
- 21 CFR 872.3930
- Specialty
- Dentistry & Oral Surgery
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MANUFACTURING SITE LOCATED IN ANÞASCO, PUERTO RICO TO PERFORM POST-ALKALI TREATMENT STEPS FOR THE ABSORBABLE COLLAGEN SPONGE (ACS).
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.